Langerhans cell migration in mice requires intact type I interleukin 1 receptor (IL-1RI) function

Archives of Dermatological Research

Volumn 291, Issue 6, 1999, Pages 357-361

  Cumberbatch, M ^a   Dearman, R J ^a   Kimber, I ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Contact sensitization; Dendritic cells; Epidermal cytokines; Interleukin 1 receptors; Langerhans cells

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL MIGRATION; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL MOVEMENT; DENDRITIC CELLS; LANGERHANS CELLS; MICE; MICE, INBRED BALB C; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE I; RECEPTORS, INTERLEUKIN-1 TYPE II; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032972959     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050422     Document Type: Article

References (31)

1. Arend WP (1993) Interleukin-1 receptor antagonist. Adv Immunol 54:167-227
2. Bigler CF, Norris DA, Weston WL, Arend WP (1992) Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 98:38-44
3. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Strone M, Giri JG, Dower SK, Sims JE, Mantovani A (1993) Interleukin 1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472-475
4. Cumberbatch M, Kimber I (1992) Dermal tumour necrosis factor-α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans cell migration. Immunology 75:257-263
5. Cumberbatch M, Kimber I (1995) Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84: 31-35
6. Cumberbatch M, Fielding I, Kimber I (1994) Modulation of epidermal Langerhans cell frequency by tumour necrosis factor-α. Immunology 81:395-401
7. Cumberbatch M, Dearman RJ, Kimber I (1996) Adhesion molecule expression by epidermal Langerhans cells and lymph node dendritic cells: a comparison. Arch Dermatol Res 288:739-744
8. Cumberbatch M, Dearman RJ, Kimber I (1997a) Interleukin 1β and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor α. Arch Dermatol Res 289:277-284
9. Cumberbatch M, Dearman RJ, Kimber I (1997b) Langerhans cells require signals from both tumour necrosis factor-α and interleukin-1β for migration. Immunology 92:388-395
10. Cumberbatch M, Dearman RJ, Kimber I (1998) Characteristics and regulation of the expression of interleukin 1 receptors by murine Langerhans cells and keratinocytes. Arch Dermatol Res 290:688-695
11. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP (1991) Interleukin 1 (IL-1) receptor antagonist binds to the 80 kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 266:10331-10336
12. Eisenberg SP, Evans RJ, Arend WP, Verdeiber E, Brewer MT, Hannum CH, Thompson RC (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-346
13. Enk AH, Katz SI (1992) Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-1402
14. Enk AH, Angeloni VL, Udey MC, Katz SI (1993) An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J Immunol 150:3698-3704
15. Furue M, Chang CH, Tamaki K (1996) Interleukin 1 but not tumour necrosis factor α synergistically upregulates the granulocyte-macrophage colony-stimulating factor-induced B7-1 expression of murine Langerhans cells. Br J Dermatol 135:194-198
16. Groves RW, Giri J, Sims J, Dower SK, Kupper TS (1995) Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes: implications for IL-1 mediated processes in epidermis. J Immunol 154:4065-4072
17. Heufler C, Koch F, Schuler G (1988) Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167:700-705
18. Kanakaraj P, Schafer PH, Cavender DE, Wu Y, Ngo K, Grealish PF, Wadsworth SA, Peterson PA, Siekierka JJ, Harris CA, Fung-Leung W-P (1998) Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signalling pathways and IL-6 production. J Exp Med 187:2073-2079
19. Kondo S, Pastore S, Fujisawa H, Shivji GN, McKenzie RC, Dinarello CA, Sauder DN (1995) Interleukin-1 receptor antagonist suppresses contact hypersensitivity. J Invest Dermatol 105:334-338
20. Labow M, Shuster D, Zetterstrom M, Nunes P, Terry R, Cullinan EB, Bartfai T, Solorzano C, Moldawer LL, Chizzonite R, McIntyre KW (1997) Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J Immunol 159:2452-2461
21. Larregina A, Morelli A, Kolkowski E, Fainboim L (1996) Flow cytometric analysis of cytokine receptors on human Langerhans cells. Changes observed after short-term culture. Immunology 87:317-325
22. Munoz E, Zubiaga AM, Sims JE, Huber BT (1991) IL-1 signal transduction pathways. I. Two functional IL-1 receptors are expressed in T-cells. J Immunol 146:136-143
23. Ozawa H, Nakagawa S, Tagami H, Aiba S (1996) Interleukin-1β and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J Invest Dermatol 106:441-445
24. Price AA, Cumberbatch M, Kimber I, Ager A (1997) α6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med 186:1725-1735
25. Ruggiero P, Bossu P, Macchia G, Del Grosso E, Sabbatini V, Bertini R, Colagrande A, Bizzarri C, Maurizi G, Di Cioccio V, D'Andrea G, Di Giulio A, Frigerio F, Grifantini R, Grandi G, Tagliabue A, Boraschi D (1997) Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II. J Immunol 158:3881-3887
26. Ryffel B, Brockhaus M, Greiner B, Mihatsch MJ, Gudat F (1991) Tumour necrosis factor receptor distribution in human lymphoid tissue. Immunology 74:446-452
27. Shornick LP, De Togni P, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Ferguson TA, Chaplin DD (1996) Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene. J Exp Med 183:1427-1436
28. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein KH, Dower SK (1993) Interleukin 1 signalling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA 90:6155-6162
29. Steinman R, Hoffman L, Pope M (1995) Maturation and migration of cutaneous dendritic cells. J Invest Dermatol 105:2S-7S
30. Symons JA, Eastgate JA, Duff GW (1991) Purification and characterization of a novel soluble receptor for interleukin-1. J Exp Med 174:1251-1254
31. Wang B, Fujisawa H, Zhuang L, Kondo S, Shivji GM, Kim CS, Mak TW, Sauder DN (1997) Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol 159:6148-6155